Sublingual nifedipine and captopril in hypertensive urgencies and emergencies. 1993

V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
Department of Medicine and Pharmacology, L.T.M. Medical College and Hospital, Sion, Bombay.

Fifty two patients of severe hypertension, diastolic blood pressure > or = 115 mmHg, with or without acute complications, were treated with sublingual nifedipine 10 mg or sublingual captopril 25 mg in a randomized prospective in patient study with careful clinical monitoring. Both the drugs were safe and effective in rapidly lowering blood pressure. Nifedipine appeared to be superior to captopril with earlier onset of action, greater magnitude of response and longer duration of action. No significant side effects were observed in either of the two groups.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D003971 Diastole Post-systolic relaxation of the HEART, especially the HEART VENTRICLES. Diastoles
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D005260 Female Females

Related Publications

V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
February 1990, Japanese journal of pharmacology,
V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
June 1993, Postgraduate medical journal,
V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
August 1992, Archives of internal medicine,
V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
November 1991, Angiology,
V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
January 1993, Nephron,
V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
May 1986, American heart journal,
V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
February 1992, International journal of clinical pharmacology, therapy, and toxicology,
V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
October 1991, Lancet (London, England),
V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
September 1985, Lancet (London, England),
V N Dadkar, and N D Karnik, and M Izar, and S R Sharma, and Y P Gandhi, and N M Narawane, and S S Vyawahare, and S Sudhakar, and A G Gore, and N M Kapadia
June 1987, Medicina clinica,
Copied contents to your clipboard!